Editor-in-Chief, Deputy Editor 2017-2019

 

Editor-in-Chief:

Tom MOREELS

 

Deputy Editor:

Nicolas LANTHIER

 

Original Article



An anti-preS2 antibody protects human hepatocytes from hepatitis B virus infection


Price: €10,00

Abstract Background : Hepatitis B virus infection is a major problem in liver transplantation. In this study, we examined the potential efficay of a recombinant adenovirus expressing an antibody against the HBV preS2 antigen (Ab-H-HBV-S2) in preventing HBV recurrent infection after liver transplantation. Methods : A gene for humanized antibody against the HBV preS2 antigen was cloned into pDC315, a type 5 adenoviral shuttle plasmid. Recombinant virus was obtained by homologous recombination in the 293 packaging cells. The virus containing the Ab-HHBV- S2 gene was transduced into the rat liver graft during cold preservation. The recombinant virus produced antibody and showed protective effects on human hepatocytes from hepatitis B virus infection in vitro. Results : The recombinant virus titer determined by TCID50 analysis was 5.1×1010 PFU/mL. The concentration of preS2 antibody in BALB/C nude mice was 16.7 ± 10.5 μg/mL on day 3, 30.9 ± 13.6 μg/mL on day 7, and lasted for 5 weeks after the injection. At a concentration of 0.5 μg/mL or above, the preS2 antibody protected cultured human hepatocytes from hepatitis B virus. Conclusions : Adenovirus-mediated gene transduction of antipreS2 antibody in the transplanted liver may be a useful approach to prevent hepatitis B infection after liver transplantation. (Acta gastro enterol. belg., 2009, 72, 306-311). [Product Details...]



Diagnostic value of antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibody in Iranian patients with inflammatory bowel disease


Price: €10,00

Abstract Background and study aims : Perinuclear antineutrophil cytoplasmic autoantibodies (pANCA) and anti-Saccharomyces Cerevisiae antibody (ASCA) are potential markers for diagnosis of inflammatory bowel disease (IBD). The aim of the present study was to evaluate the diagnostic value of pANCA and ASCA in Iranian patients with IBD. Patients and Methods : Serum samples were collected from 144 patients with IBD (113 ulcerative colitis and 31 Crohn’s disease) and patients with non-IBD problems were assayed for ASCA by Enzyme-Linked Immunosorbent Assay (ELISA) and for pANCA by indirect immunofluorescence assay. Results : Sensitivity and specificity of pANCA in UC were 39.8% and 82.1%, respectively. For CD, pASCA test provided the sensitivity of 58% and specificity of 70%. A combination of pANCA+/ASCA- for diagnosis of UC showed a sensitivity of 31.9% and specificity of 89.1%. In addition the combination of pANCA-/ASCA+ showed a sensitivity of 35.5% and specificity of 79.8% for diagnosis of CD. Conclusion : Due to low sensitivity of pANCA and ASCA alone or in combination, they are not valuable serological markers for diagnosis of UC or CD. (Acta gastro enterol. belg., 2009, 72, 301-305). [Product Details...]



High fat consumption in children with celiac disease


Price: €10,00

Abstract Aim : The purpose of this study was to estimate the caloric intake and fat consumption in children with celiac disease (CD) following a gluten-free diet (GFD). Patients and methods : This study enrolled 100 subjects, including 50 children with CD on a gluten-free diet and a control group of 50 healthy children. Statistical analysis to compare groups was performed using one-way ANOVA. Results : A significant increase in fat consumption was observed in children with CD as compared to healthy children. The daily fat intake was 72.5 ± 37.2 g per 100 g of food in the CD group and 52.9 ± 35.4 g per 100 g of food in the control group (p l. belg., 2009, 72, 296-300). [Product Details...]



Octreotide in chemotherapy induced diarrhoea in colorectal cancer : a review article


Price: €10,00

Abstract Background : Chemotherapy-induced diarrhoea (CID) is well known in cancer management. The risk is greater when the primary cancer is colorectal. This article aims towards assessing the role of octreotide in CID through an extensive literature search. Methods : After searching through PUBMED, MEDLINE and the Cochrane library, only those studies which were published over the last 20 years in English and where at least the majority of the cohort were colorectal patients, were included. Two randomized trials, four non-randomized studies and two case-series publications were thus considered. Results : It was seen in both the randomized studies, that octreotide had much better outcome as compared to loperamide in treating severe CID. Among 88 patients from the non-randomized studies with severe CID, the primary cancer was colorectal in 79 patients. 61 patients had drug-resistant CID. Within a maximum of 96 hours, octreotide reduced CID by 2 grades in 91% of 88 patients and in 88.52% patients with drug-resistant CID. Conclusion : Octreotide is effective in treating severe CID, resistant to other modes of treatment. It is associated with a few minor adverse effects. Though expensive, octreotide could be considered as first line medication in CID of grades 3 or above. Its use in lower grades of CID would not be cost effective. (Acta gastro enterol. belg., 2009, 72, 289-295). [Product Details...]



Physiologic variables for videofluoromanometric assessment of dysphagia : an exploratory study


Price: €10,00

Abstract Study Aim : To assess the physiological variables among Upper Esophageal Sphincter Nadir (UESN), Hypopharyngeal Peak Pressure (HPP) and Pharyngo-Esophageal Pressure Gradient (PEPG) for Videofluoromanometry (VFM). Patients & Method : Exploratory non-randomised prospective study comparing UESN, HPP and PEPG of three cohorts of individuals presumably presenting very distinctive “manometric signatures” based on McConnel’s Piston Model of swallowing : 11 non-dysphagic volunteers called the Control Group (CG), 10 dysphagic patients presenting a Myotonic Dystrophy (MD), at various stages of evolution, and 10 patients presenting a Crico- Pharyngeal Barr (CPB), with no post-swallow pharyngeal residue at a previous Modified Barium Swallow (MBS). VFM tests are performed using solid-state three unidirectional transducers produced by Gaeltec Inc. The simultaneous display storage of the standard fluoroscopic swallow of 10 ml liquid barium with UESN and HPP measurements, continuously recorded on a 3-channel polygraph, is performed using a Kay-Pentax Swallowing Work Station. PEPG calculations are subsequently made. Results : Significant different HPP and PEPG values were observed between the three cohorts. MD patients presented HPP and PEPG below 100 mmHg while CPB patients presented HPP and PEPG above 200 mmHg. The CG presented HPP and PEPG between 100 and 200 mmHg. UESN values revealed no significant difference between the three cohorts. A reading scale is proposed. The aim of the scale is to make a link between HPP or PEPG values and physiopathological (not diagnostic) conditions. Patients presenting an HPP or PEPG below 100 mmHg indicate a High probability of Pharyngeal Propulsion Impairment while patients presenting an HPP or PEPG above 200 mmHg are more likely to have an Increased Flow Resistance with appropriate Propulsion Response. Pros and cons for calculation of the PEPG, representing a possibly unnecessary step, are discussed. Conclusions : In our study, the use of HPP or PEPG as physiological variables provides quantitative data that allow VFM to discriminate three very distinctive swallowing conditions. Further studies are needed to assess the HPP and PEPG obtained with other manometic devices within the same specific populations for them to be considered as universal physiological variables. Eventually, further investigations should answer the question as to whether the calculation of the PEPG represents any value in comparison with HPP measurement alone. (Acta gastro enterol. belg., 2009, 72, 312-320). Key words : videofluoromanometry, dysphagia, my [Product Details...]


  • «« Start
  • « Prev
  • 1
  • Next »
  • End »»
Results 1 - 5 of 5